64 completed, 10 terminated, 10 unknown, 7 recruiting. 101 Phase 1, 45 Phase 2.
Follow control: new trials by email Literature Review of control trials Research Report on control
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Opt-IVF for Personalized Medicine for Normal Responders Opt-IVF, control - Ivf | Phase 1 / Phase 2 | Active not recruiting | Urmila DIwekar | 100 | 2026-10-15 | 2026-11-03 |
| CBD for Breast Cancer Primary Tumors CBD Oral, Control - Breast Cancer | Phase 1 | Recruiting | Medical University of South Carolina | 84 | 2026-09-18 | 2026-09-28 |
| dMD-002 Pilot Study in Patients With Cavernous Nerve Injury Following Radical Prostatectomy dMD-002, Control - Prostate Cancer | Phase 1 / Phase 2 | Not yet recruiting | Mochida Medical USA, Inc. | 30 | 2026-08-01 | 2026-05-15 |
| Morning-Evening Specific Longevity Food Supplement Morning- and evening-specific compound food supplement, Control - Aging | Phase 1 | Active not recruiting | University of Primorska | 60 | 2026-03-07 | 2026-03-11 |
| An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization for Provera Opt-IVF, Control - Infertility (IVF Patients) | Phase 1 / Phase 2 | Recruiting | Urmila DIwekar | 200 | 2025-09-23 | 2025-09-29 |
| Trial on Single/Multiple Ascending Doses for Safety, PK and PD for CBP-0276 in Healthy Subjects CBP-0276 Acetate, Placebo for CBP-0276 Acetate - Healthy Volunteers | Phase 1 | Completed | Clarent Biopharma, Inc. | 64 | 2025-09-04 | 2026-10-16 |
| Nurse-Led Elderly Sleep Intervention Otago programme, Otago programme + Cognifit, Control - Sleep, Gerontology | Phase 1 / Phase 2 | Completed | University of Castilla-La Mancha | 66 | 2025-09-01 | 2026-05-22 |
| A Robot-assisted Tailored Activity Programme for People With Dementia and Their Caregivers Intervention, Control - Dementia, Caregiver | Phase 1 | Recruiting | The Hong Kong Polytechnic University | 60 | 2025-09-01 | 2025-12-18 |
| Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients phage therapy, control - Urinary Tract Infection, Recurrent | Phase 1 / Phase 2 | Recruiting | University of California, San Diego | 32 | 2025-06-15 | 2025-08-14 |
| Evaluating the Impact of Adjuvant Use of Beta Blockers on Clinical Outcomes in Patients With Traumatic Brain Injury control, propranolol, Carvedilol - TBI Traumatic Brain Injury | Phase 1 / Phase 2 | Recruiting | Mansoura University | 100 | 2025-01-20 | 2025-04-02 |
| SBI for PSM and PSD F2F, eSBI, Control - Prescription Stimulant Misuse, Prescription Stimulant Diversion | Phase 1 | Enrolling by invitation | California State University, Long Beach | 120 | 2024-10-01 | 2025-05-04 |
| MSC EVs in Dystrophic Epidermolysis Bullosa AGLE-102 - Dystrophic Epidermolysis Bullosa | Phase 1 / Phase 2 | Recruiting | Aegle Therapeutics | 8 | 2024-08-13 | 2025-06-25 |
| Crizanlizumab Improves Tissue Oxygen Supply Demand Matching in Patients With Sickle Cell Anemia Crizanlizumab, control - Sickle Cell Disease | Phase 1 / Phase 2 | Not yet recruiting | Children's Hospital Los Angeles | 30 | 2024-07-01 | 2023-08-30 |
| Effects of Platelet-Rich Fibrin on Postoperative Outcomes Following Nasosinusal Surgery Platelet-rich fibrin (PRF), Control - Turbinate Surgery | Phase 1 / Phase 2 | Completed | Hospital Edmundo Vasconcelos | 14 | 2024-06-15 | 2026-06-12 |
| Fluorescence Imaging of Adalimumab-680LT in Inflammatory Bowel Disease Adalimumab-680LT, Control - Crohn Disease, Ulcerative Colitis | Phase 1 / Phase 2 | Unknown | University Medical Center Groningen | 21 | 2024-03-01 | 2024-03-12 |
| Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis Mesenchymal stem cells, Placebo - Chronic Pancreatitis, Chronic Pain | Phase 1 | Recruiting | VA Office of Research and Development | 40 | 2024-01-01 | 2026-04-07 |
| Effect of Kinesio Tape Versus Systemic Dexamethasone on Postsurgical Sequels Following Extraction of Impacted Mandibular Third Molars Kinesio Tape application, Intramuscular Injection of Dexamethasone, control - Impacted Mandibular Third Molar Extraction | Phase 1 | Completed | Ashraf elanzy | 30 | 2023-10-01 | 2026-01-20 |
| Safety, Tolerability, Pharmacokinetics and Protective Efficacy of MAM01 in Healthy Adults MAM01 1.5 mg/kg, Placebo, MAM01 5 mg/kg - Malaria | Phase 1 | Completed | Gates Medical Research Institute | 63 | 2023-08-14 | 2026-06-12 |
| Solidarity/Tokomeza Ebola Trial CAd3, ChAdox1, rVSV-SUDV - Sudan Ebola Virus Vaccines | Phase 1 / Phase 2 | Not yet recruiting | Makerere University | 2121 | 2023-07-01 | 2023-06-18 |
| A Study of Levofloxacin Ocular Implant in Patients Undergoing Routine Bilateral Cataract Surgery Levofloxacin Ocular Implant, Control - Cataract | Phase 1 | Withdrawn | PolyActiva Pty Ltd | 2023-06-23 | 2024-04-12 |
Showing 20 of 101. Sign in to see all of them.
Motor Activity (9) · Diabetes Mellitus, Type 1 (4) · Parkinson Disease (4) · COVID-19 (3) · Breast Neoplasms (2) · Chronic Pain (2) · Dementia (2) · Diabetes Mellitus (2) · Diabetes Mellitus, Type 2 (2) · Enterocolitis, Necrotizing (2) · Heart Diseases (2) · Idiopathic Pulmonary Fibrosis (2) · Infertility (2) · Macular Edema (2) · Myocardial Infarction (2)
Johns Hopkins University (4) · Kinderkrankenhaus auf der Bult (3) · Royan Institute (3) · VA Office of Research and Development (3) · Washington University School of Medicine (3) · Affiris AG (2) · AstraZeneca (2) · Kasiak Research Pvt. Ltd. (2) · Mayo Clinic (2) · Medical University of South Carolina (2) · Pfizer (2) · University of California, San Diego (2) · University of Isfahan (2) · Urmila DIwekar (2) · Aegle Therapeutics (1)
United States (49) · Canada (8) · Germany (4) · United Kingdom (4) · Egypt (3) · India (3) · Iran (3) · Mexico (3) · Australia (2) · Austria (2) · Brazil (2) · China (2) · Spain (2) · Bangladesh (1) · Bulgaria (1)
Ashraf Moini, MD (2) · Burton M Wice, PhD (2) · Dominic Reeds, MD (2) · Marzieh Shiva, MD (2) · Santiago A Garcia, MD (2) · Thomas Danne, MD (2) · Alexander Pantelyat, MD (1) · Alexandre Biasi, MD/PhD (1) · Amin R Javer, MD, FRCSC (1) · Ann C Skulas-Ray, PhD (1) · Berthold Bein, MD (1) · Bruce A Buckingham, MD (1) · Cathy M Arnold, MSc (1)
PMID 30741694, PMID 15125017, PMID 17707752, PMID 19508973, PMID 19559969, PMID 19794023, PMID 20418657, PMID 22231013, PMID 22505632, PMID 22776413, PMID 22818551, PMID 23701746, PMID 23741380, PMID 24429129, PMID 24712447, PMID 24997137, PMID 25064164, PMID 25104129, PMID 25252696, PMID 25722291, PMID 25853697, PMID 25927273, PMID 26340878, PMID 26545726, PMID 27222506, PMID 27288245, PMID 27322478, PMID 27688236, PMID 27777606, PMID 28254171, PMID 28356431, PMID 28591764, PMID 28735720, PMID 28939263, PMID 29659952, PMID 29906796, PMID 30906944, PMID 32526149, PMID 34306677, PMID 34975844, PMID 36645250, PMID 37251511, PMID 38970537, PMID 39272232, PMID 41005346, PMID 41925207, PMID 42775498
2014 (1), 2018 (1), 2023 (1), I01CX002516 (1), IK2CX002286 (1), R00NR016484 (1), R01AG027874 (1), R01DK088126 (1), R01MH062717 (1), R01NS052448 (1), R21CA152433 (1), R34DA056596 (1)